Bradycardia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements 2. Patient is intended to be treated with an eligible product 3. Patient within enrollment window of therapy received at the time of their initial PSR platform enrollment
Exclusion criteria
Exclusion criteria: 1. Patient who is, or is expected to be inaccessible for follow-up 2. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the acute major complication rate related to the Micra system and/or Micra system implant procedure. | — |
Countries
Japan
Contacts
Medtronic Japan Co.,Ltd. Japan Clinical and Medical Affairs